Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors
Sandeep K. Tripathy, Hugh B. Black, Eugene Goldwasser et al. · Nature Medicine · 1996
Cited by 628 works. doi:10.1038/nm0596-545
Authors
References
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
- Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
- Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice
- Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
- Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses
- Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
- Adenovirus as an expression vector in muscle cells in vivo.
- Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.
- MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses